202 related articles for article (PubMed ID: 30553523)
21. Synthesis of a heterotrifunctional linker for the site-specific preparation of antibody-drug conjugates with two distinct warheads.
Kumar A; Kinneer K; Masterson L; Ezeadi E; Howard P; Wu H; Gao C; Dimasi N
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3617-3621. PubMed ID: 30389292
[TBL] [Abstract][Full Text] [Related]
22. Potential drugs used in the antibody-drug conjugate (ADC) architecture for cancer therapy.
Yaghoubi S; Karimi MH; Lotfinia M; Gharibi T; Mahi-Birjand M; Kavi E; Hosseini F; Sineh Sepehr K; Khatami M; Bagheri N; Abdollahpour-Alitappeh M
J Cell Physiol; 2020 Jan; 235(1):31-64. PubMed ID: 31215038
[TBL] [Abstract][Full Text] [Related]
23. Pushing the Envelope: Advancement of ADCs Outside of Oncology.
McPherson MJ; Hobson AD
Methods Mol Biol; 2020; 2078():23-36. PubMed ID: 31643047
[TBL] [Abstract][Full Text] [Related]
24. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
Tsuchikama K; An Z
Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
[TBL] [Abstract][Full Text] [Related]
25. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
[TBL] [Abstract][Full Text] [Related]
26. Antibody-drug conjugates: a mini-review. The synopsis of two approved medicines.
Papachristos A; Pippa N; Demetzos C; Sivolapenko G
Drug Deliv; 2016 Jun; 23(5):1662-6. PubMed ID: 25625494
[TBL] [Abstract][Full Text] [Related]
27. Chimeric Small Antibody Fragments as Strategy to Deliver Therapeutic Payloads.
Aguiar S; Dias J; Manuel AM; Russo R; Gois PMP; da Silva FA; Goncalves J
Adv Protein Chem Struct Biol; 2018; 112():143-182. PubMed ID: 29680236
[TBL] [Abstract][Full Text] [Related]
28. Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies.
Rios-Doria J; Harper J; Rothstein R; Wetzel L; Chesebrough J; Marrero A; Chen C; Strout P; Mulgrew K; McGlinchey K; Fleming R; Bezabeh B; Meekin J; Stewart D; Kennedy M; Martin P; Buchanan A; Dimasi N; Michelotti E; Hollingsworth R
Cancer Res; 2017 May; 77(10):2686-2698. PubMed ID: 28283653
[TBL] [Abstract][Full Text] [Related]
29. Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates.
Hinrichs MJM; Ryan PM; Zheng B; Afif-Rider S; Yu XQ; Gunsior M; Zhong H; Harper J; Bezabeh B; Vashisht K; Rebelatto M; Reed M; Ryan PC; Breen S; Patel N; Chen C; Masterson L; Tiberghien A; Howard PW; Dimasi N; Dixit R
Clin Cancer Res; 2017 Oct; 23(19):5858-5868. PubMed ID: 28630216
[No Abstract] [Full Text] [Related]
30. Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads.
Donnell AF; Zhang Y; Stang EM; Wei DD; Tebben AJ; Perez HL; Schroeder GM; Pan C; Rao C; Borzilleri RM; Vite GD; Gangwar S
Bioorg Med Chem Lett; 2017 Dec; 27(23):5267-5271. PubMed ID: 29102228
[TBL] [Abstract][Full Text] [Related]
31. Amanitins and their development as a payload for antibody-drug conjugates.
Pahl A; Lutz C; Hechler T
Drug Discov Today Technol; 2018 Dec; 30():85-89. PubMed ID: 30553524
[TBL] [Abstract][Full Text] [Related]
32. Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells.
Chen R; Rajan S; Overstreet MG; Hurt EM; Thomas SB; Muniz-Medina V; Ward C; Sadowska A; Fleming R; Karanth S; Breen S; Zheng B; Wu Y; Iverson WO; Novick S; O'Day T; Shah DP; Dimasi N; Tiberghien AC; Osbourn J; Walker J
Mol Cancer Ther; 2020 Aug; 19(8):1649-1659. PubMed ID: 32404408
[TBL] [Abstract][Full Text] [Related]
33. From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).
Mantaj J; Jackson PJ; Rahman KM; Thurston DE
Angew Chem Int Ed Engl; 2017 Jan; 56(2):462-488. PubMed ID: 27862776
[TBL] [Abstract][Full Text] [Related]
34. Computationally designed antibody-drug conjugates self-assembled via affinity ligands.
Gupta N; Ansari A; Dhoke GV; Chilamari M; Sivaccumar J; Kumari S; Chatterjee S; Goyal R; Dutta PK; Samarla M; Mukherjee M; Sarkar A; Mandal SK; Rai V; Biswas G; Sengupta A; Roy S; Roy M; Sengupta S
Nat Biomed Eng; 2019 Nov; 3(11):917-929. PubMed ID: 31686001
[TBL] [Abstract][Full Text] [Related]
35. Risk-Based Pharmacokinetic and Drug-Drug Interaction Characterization of Antibody-Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective.
Li C; Menon R; Walles M; Singh R; Upreti VV; Brackman D; Lee AJ; Endres CJ; Kumar S; Zhang D; Barletta F; Suri A; Hainzl D; Liao KH; Lalovic B; Beaumont M; Zuo P; Mayer AP; Wei D
Clin Pharmacol Ther; 2022 Oct; 112(4):754-769. PubMed ID: 34657311
[TBL] [Abstract][Full Text] [Related]
36. Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug Conjugates.
Pei Z; Chen C; Chen J; Cruz-Chuh JD; Delarosa R; Deng Y; Fourie-O'Donohue A; Figueroa I; Guo J; Jin W; Khojasteh SC; Kozak KR; Latifi B; Lee J; Li G; Lin E; Liu L; Lu J; Martin S; Ng C; Nguyen T; Ohri R; Lewis Phillips G; Pillow TH; Rowntree RK; Stagg NJ; Stokoe D; Ulufatu S; Verma VA; Wai J; Wang J; Xu K; Xu Z; Yao H; Yu SF; Zhang D; Dragovich PS
Mol Pharm; 2018 Sep; 15(9):3979-3996. PubMed ID: 30040421
[TBL] [Abstract][Full Text] [Related]
37. Clinical toxicity of antibody drug conjugates: a meta-analysis of payloads.
Masters JC; Nickens DJ; Xuan D; Shazer RL; Amantea M
Invest New Drugs; 2018 Feb; 36(1):121-135. PubMed ID: 29027591
[TBL] [Abstract][Full Text] [Related]
38. Sequence-selective binding of C8-conjugated pyrrolobenzodiazepines (PBDs) to DNA.
Basher MA; Rahman KM; Jackson PJM; Thurston DE; Fox KR
Biophys Chem; 2017 Nov; 230():53-61. PubMed ID: 28941814
[TBL] [Abstract][Full Text] [Related]
39. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates.
Frigerio M; Kyle AF
Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801
[TBL] [Abstract][Full Text] [Related]
40. UPLC-based assay to assess the hydrophobicity of Antibody-Drug Conjugate (ADC) payloads.
Pysz I; Jackson PJM; Barlow DJ; Rahman KM; Thurston DE
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun; 1146():122075. PubMed ID: 32361467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
